ABI3 and bladder transitional cell carcinoma: Furthermore, according to the forest plot for PFS in Figure 4D, ABI3 expression was found to be a risk factor in STAD, HNSC, and KIRP, but a protective factor for patients with ACC, BLCA, CESC, KIRC, COAD, LIHC, and LUAD.